Francisco Javier Barón-López

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

Óscar Fernández, Guillermo Izquierdo, Victoria Fernández et al. · PLoS ONE · 2018 · 154 citations · Full text

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

Laura Muinelo‐Romay, María Vieito, Alicia Abalo et al. · Cancers · 2014 · 102 citations · Full text

Circulating Tumor Cells, Cancer Management, Pathology +17

School Teachers’ Vocal Use, Risk Factors, and Voice Disorder Prevalence: Guidelines to Detect Teachers with Current Voice Problems

Rosa M. Bermúdez de Alvear, Francisco Javier Barón-López, Antonio Ginés Martínez-Arquero · Folia Phoniatrica et Logopaedica · 2010 · 92 citations

Reliability and criterion-related validity with a smartphone used in timed-up-and-go test

Alejandro Galán-Mercant, Francisco Javier Barón-López, María Teresa Labajos Manzanares et al. · BioMedical Engineering OnLine · 2014 · 88 citations · Full text

Additive effects of LPL, APOA5 and APOEvariant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study

María José Ariza, Miguel-Ángel Sánchez-Chaparro, Francisco Javier Barón-López et al. · BMC Medical Genetics · 2010 · 66 citations · Full text